{"transactions":[{"id":692716,"issuer":{"id":4564,"kind":"organization","name":"Braveheart Bio, Inc."},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-07T20:31:15.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the stock option will vest in full upon the earlier of (i) August 5, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":18,"expiration_date":"2036-08-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001470831-26-000801","document":"wk-form4_1786134672.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1774478/000147083126000801/wk-form4_1786134672.xml","form_type":"4"}},{"id":692715,"issuer":{"id":4564,"kind":"organization","name":"Braveheart Bio, Inc."},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-07T20:31:15.000Z","date":"2026-08-07","kind":"purchase","planned":false,"acquired":true,"shares":83333,"price":18,"value":1499994.0,"ownership":{"direct":true},"balance_after":609519,"source":{"system":"sec-edgar","filing":"0001470831-26-000801","document":"wk-form4_1786134672.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1774478/000147083126000801/wk-form4_1786134672.xml","form_type":"4"}},{"id":903286,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:18:48.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":38015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":38015,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":38015},"source":{"system":"sec-edgar","filing":"0000875045-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000035/form4.xml","form_type":"4"}},{"id":913200,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:06:49.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":15453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":30907,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":15453},"source":{"system":"sec-edgar","filing":"0000875045-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000024/form4.xml","form_type":"4"}},{"id":913199,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:06:49.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":9008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":9009,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":9008},"source":{"system":"sec-edgar","filing":"0000875045-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000024/form4.xml","form_type":"4"}},{"id":913198,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-10T22:06:49.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":6624,"price":201.18,"value":1332616.32,"ownership":{"direct":true},"balance_after":29924,"source":{"system":"sec-edgar","filing":"0000875045-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000024/form4.xml","form_type":"4"}},{"id":913197,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-10T22:06:49.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":15453,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36548,"source":{"system":"sec-edgar","filing":"0000875045-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000024/form4.xml","form_type":"4"}},{"id":913196,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-10T22:06:49.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":4356,"price":201.18,"value":876340.08,"ownership":{"direct":true},"balance_after":21095,"source":{"system":"sec-edgar","filing":"0000875045-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000024/form4.xml","form_type":"4"}},{"id":913195,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-10T22:06:49.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":9008,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25451,"source":{"system":"sec-edgar","filing":"0000875045-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000024/form4.xml","form_type":"4"}},{"id":982640,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-12-03T21:42:56.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":false,"shares":7040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU vested on the third anniversary of the grant date of December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU vested on the third anniversary of the grant date of December 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7040},"source":{"system":"sec-edgar","filing":"0000875045-25-000052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504525000052/form4.xml","form_type":"4"}},{"id":982639,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-03T21:42:56.000Z","date":"2025-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3404,"price":177.78,"value":605163.12,"ownership":{"direct":true},"balance_after":16443,"source":{"system":"sec-edgar","filing":"0000875045-25-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504525000052/form4.xml","form_type":"4"}},{"id":982638,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-03T21:42:56.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":true,"shares":7040,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19847,"source":{"system":"sec-edgar","filing":"0000875045-25-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504525000052/form4.xml","form_type":"4"}},{"id":1277553,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:55:55.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":9008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":18017,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":9008},"source":{"system":"sec-edgar","filing":"0001127602-25-003962","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003962/form4.xml","form_type":"4"}},{"id":1277552,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:55:55.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":46360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":46360,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":46360},"source":{"system":"sec-edgar","filing":"0001127602-25-003962","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003962/form4.xml","form_type":"4"}},{"id":1277551,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-10T23:55:55.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":3201,"price":141.35,"value":452461.35,"ownership":{"direct":true},"balance_after":12807,"source":{"system":"sec-edgar","filing":"0001127602-25-003962","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003962/form4.xml","form_type":"4"}},{"id":1277550,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-10T23:55:55.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":9008,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16008,"source":{"system":"sec-edgar","filing":"0001127602-25-003962","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003962/form4.xml","form_type":"4"}},{"id":1652207,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T00:56:57.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":27025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":27025,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":27025},"source":{"system":"sec-edgar","filing":"0001127602-24-004302","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004302/form4.xml","form_type":"4"}},{"id":2097176,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Performance Stock Unit","published_at":"2022-12-05T22:11:40.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":45998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance Stock Unit (\"PSU\") or Restricted Stock Unit (\"RSU\") represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This represents the reporting person's PSUs that will be eligible for vesting based on achievement of absolute stock price compound annual growth rate goals (\"Absolute CAGR PSUs\") over a three-year performance period ending on November 30, 2025. The number of Absolute CAGR PSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This represents the reporting person's PSUs that will be eligible for vesting based on achievement of absolute stock price compound annual growth rate goals (\"Absolute CAGR PSUs\") over a three-year performance period ending on November 30, 2025. The number of Absolute CAGR PSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout."}],"balance_after":45998,"derivative":{"underlying":"Common Stock","underlying_shares":45998},"source":{"system":"sec-edgar","filing":"0001127602-22-026909","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026909/form4.xml","form_type":"4"}},{"id":2097175,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2022-12-05T22:11:40.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":7040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance Stock Unit (\"PSU\") or Restricted Stock Unit (\"RSU\") represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU is eligible to vest on the third anniversary of the grant date of December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU is eligible to vest on the third anniversary of the grant date of December 1, 2022."}],"balance_after":7040,"derivative":{"underlying":"Common Stock","underlying_shares":7040},"source":{"system":"sec-edgar","filing":"0001127602-22-026909","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026909/form4.xml","form_type":"4"}},{"id":2097174,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-12-05T22:11:40.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":80522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Options are eligible to vest and become exercisable in approximately equal annual installments on the first, second and third anniversaries of the grant date of December 1, 2022."}],"balance_after":80522,"derivative":{"exercise_price":301.85,"expiration_date":"2032-12-01","underlying":"Common Stock","underlying_shares":80522},"source":{"system":"sec-edgar","filing":"0001127602-22-026909","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026909/form4.xml","form_type":"4"}}]}